Interchange Capital Partners, LLC
Source: SEC Form 13F · as of Mar 2026Interchange Capital Partners, LLC holds 18 biotech & pharma companies tracked by BioSniper, totaling $14.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$14.9M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 15,019 | $3.2M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 4,293 | $2.2M |
| ABTABBOTT LABORATORIES | 15,509 | $2.0M |
| LLYELI LILLY & Co | 1,270 | $1.1M |
| MRKMerck & Co., Inc. | 10,573 | $993K |
| PMPhilip Morris International Inc | 6,098 | $971K |
| JNJJOHNSON & JOHNSON | 4,848 | $861K |
| MCKMcKesson Corporation | 794 | $553K |
| AMGNAMGEN INC | 1,636 | $517K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 919 | $443K |
| GMOptec International, Inc. | 7,811 | $393K |
| GILDGILEAD SCIENCES, INC. | 3,054 | $380K |
| PFEPFIZER INC | 16,598 | $338K |
| SNYSanofi | 4,732 | $262K |
| NVSNovartis AG | 1,995 | $234K |
| CRSPCRISPR Therapeutics AG | 6,767 | $230K |
| RXRXRECURSION PHARMACEUTICALS, INC. | 24,064 | $125K |
| NTLAIntellia Therapeutics, Inc. | 11,073 | $79K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.